🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Autologous Free Dermal Graft Support in Superior Pedicle Vertical Scar Reduction Mammaplasty

Recruitingn/aAges 18 Years - 65 YearsFemaleCumhuriyet University Hospital
NCT07657962 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn whether using an autologous free dermal graft during breast reduction surgery helps maintain lower breast pole shape over time in women undergoing primary bilateral reduction mammaplasty. The main question it aims to answer is: Does autologous free dermal graft support reduce lower pole lengthening between 1 month and 6 months after surgery? Researchers will compare two groups of participants. One group will undergo superior pedicle vertical scar reduction mammaplasty with autologous free dermal graft support as part of routine surgical care. The other group will undergo the same basic breast reduction technique without autologous free dermal graft support. Participants will: * Have their planned breast reduction surgery as part of routine care * Attend postoperative follow-up visits at 1, 3, and 6 months * Have standard breast measur

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Female participants aged 18 to 65 years * Planned primary bilateral reduction mammaplasty * Planned use of the superior pedicle vertical scar technique * Willingness to attend at least 6 months of postoperative follow-up * Ability to provide written informed consent * Consent for standardized medical photography and clinical breast measurements Exclusion Criteria: * Previous breast surgery * Oncoplastic breast reduction * Unilateral reduction mammaplasty * Use of a pedicle technique other than the superior pedicle * Use of a scar pattern other than the vertical scar pattern * Presence of a systemic condition expected to significantly impair wound healing * Active smoking within the last 6 weeks before surgery * Incomplete 6-month follow-up data for the primary outcome analysis
💊

What it tests

  • Autologous Free Dermal Graft Support
📍

Where

1 site
Sivas Cumhuriyet University
Sivas, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy